dpp4 vs sglt2 vs glp-1 Insights into the Roles of GLP-1, DPP-4, and at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Safety of SGLT2 inhibitors, DPP-4

GLP-1 receptor agonists used for the treatment of diabetes, have shown some neuroprotective effects in cellular and animal models of Alzheimers disease (AD) and Parkinsons disease (PD)

NATURALLY CURBS CRAVINGS This multi-strain probiotic is formulated with beneficial bacteria that naturally increase GLP-1,* the un-hunger hormone that helps curb cravings & appetite.

Scientifically Backed for Real Results: Clinical studies show that 10g (the amount in 4 tsp) helps promote satiety within 30 minutes after a meal and helps maintain appetite control for up to 4 hours.* Designed for convenient daily use

Hernandez shares how GLP-1 medications can help children take steps toward healthier futures

Introduction Significant reductions in cardiovascular events, all-cause mortality, and the advancement of kidney disease are demonstrated by important studies such as FLOW

Kezia Parkins asks the experts